PharmacovigilanceOfficial
AEMPS updates contraceptive advice for women taking tirzepatide with oral contraceptives
🇪🇸 AEMPS · Thu 19 Nov 2026
Spain's regulator says EMA committees found limited data on tirzepatide's effect on oral contraceptives, and now advises added barrier protection or a switch to a non-oral method.
The Spanish Agency for Medicines and Medical Devices (AEMPS) published safety note MUH (FV) 04/2026 on 19 November 2026. It sets out revised contraceptive recommendations for women treated with tirzepatide, the active substance in Mounjaro.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (AEMPS). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
EEA Joint Committee amends Annex I on veterinary and phytosanitary matters
🇪🇺 EUR-Lex · Thu 19 Nov 2026
FDA early alert: Tablo power cord connections may overheat, Outset Medical updates instructions
🇺🇸 FDA MedWatch · Wed 18 Nov 2026
EMA publishes list of Union reference dates and PSUR submission frequencies
🇪🇺 EMA · Wed 18 Nov 2026
EU Health Security Committee urges stronger action on carbapenem-resistant bacteria as infections rise
🇪🇺 European Commission (DG SANTE) · Wed 18 Nov 2026
AIFA starts rolling review of daraxonrasib after positive CHMP opinion in pancreatic cancer
🇮🇹 AIFA · Wed 18 Nov 2026
Portugal's antibiotic use stays below EU average, but broad-spectrum prescribing remains a concern
🇵🇹 INFARMED · Wed 18 Nov 2026